B. Górski

J. Kładny, R. Scott, A. Jakubowska, 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

The 3′ untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation

R. Scott, U. Hamann, A. Jakubowska, 2007, Breast Cancer Research and Treatment.

Exploring the Link between Germline and Somatic Genetic Alterations in Breast Carcinogenesis

J. Dopazo, A. Berenguer, M. Pujana, 2010, PloS one.

A common variant of CDKN2A (p16) predisposes to breast cancer

S. Narod, C. Szczylik, A. Mackiewicz, 2005, Journal of Medical Genetics.

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families

R. Scott, J. Lubiński, C. Cybulski, 2015, Hereditary cancer in clinical practice.

Common variants of xeroderma pigmentosum genes and prostate cancer risk.

R. Scott, J. Lubiński, M. Słojewski, 2014, Gene.

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population

J. Lubiński, J. Gronwald, B. Górski, 2012, Molecular Biology Reports.

Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin

J. Kładny, A. Jakubowska, J. Lubiński, 2003, Melanoma research.

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

J. Kładny, J. Lubiński, S. Narod, 2009, Breast Cancer Research and Treatment.

Increased risk of breast cancer in relatives of malignant melanoma patients from families with strong cancer familial aggregation

J. Kładny, A. Jakubowska, C. Cybulski, 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Vitamin D receptor variants and the malignant melanoma risk: a population-based study.

C. Cybulski, T. Byrski, T. Huzarski, 2009, Cancer epidemiology.

Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility

J. Kładny, R. Scott, J. Lubiński, 2010, BMC Cancer.

Vitamin D receptor variants and breast cancer risk in the Polish population

J. Kładny, J. Lubiński, C. Cybulski, 2009, Breast Cancer Research and Treatment.

CYP1B1 and predisposition to breast cancer in Poland

R. Scott, A. Jakubowska, J. Lubiński, 2007, Breast Cancer Research and Treatment.

Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer.

J. Lubiński, S. Narod, P. Sun, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical, Molecular and Geographical Features of Hereditary Breast/Ovarian Cancer in Latvia

B. Górski, Janina Suchy, Andrejs Vanags, 2005, Hereditary cancer in clinical practice.

Inherited variants in XRCC2 and the risk of breast cancer

A. Jakubowska, J. Lubiński, S. Narod, 2019, Breast Cancer Research and Treatment.

Recurrent mutations of BRCA1 and BRCA2 in Poland: an update

A. Jakubowska, J. Lubiński, S. Narod, 2015, Clinical genetics.

Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization

A. Jauch, R. Scott, B. Schoell, 2005, International journal of cancer.

Integrin b 3 Leu33Pro polymorphism increases BRCA1 associated ovarian cancer risk

U. Hamann, A. Jakubowska, J. Lubiński, 2007 .

Integrin β3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk

R. Scott, U. Hamann, A. Jakubowska, 2007, Journal of Medical Genetics.

Hereditary Colorectal Cancer (CRC) Program in Latvia

B. Górski, Janina Suchy, J. Gardovskis, 2003 .

On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations

C. Greenwood, F. Couch, W. Foulkes, 2011, European Journal of Human Genetics.

Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania–Kujawy region of Poland

J. Lubiński, B. Górski, O. Haus, 2003, Clinical genetics.

The 3020insC NOD2 gene mutation in patients with ovarian cancer.

J. Lubiński, B. Górski, K. Mędrek, 2008, Ginekologia polska.

BARD1 and breast cancer in Poland

A. Jakubowska, J. Lubiński, S. Narod, 2007, Breast Cancer Research and Treatment.

Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers.

A. Jakubowska, J. Lubiński, C. Cybulski, 2003, Journal of Applied Genetics.

Premature Menopause in Patients with BRCA1 Gene Mutation

B. Górski, A. Chudecka-Głaz, A. Tołoczko‐Grabarek, 2006, Breast Cancer Research and Treatment.

Synergistic interaction of variants in and on breast cancer risk

Bogdanova, T. Dörk, C. Cybulski, 2020 .

CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.

J. Lubiński, A. Sokolenko, E. Imyanitov, 2006, Gynecologic oncology.

Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population

B. Górski, 2006, Hereditary cancer in clinical practice.

NOD2 variants and the risk of malignant melanoma

C. Cybulski, T. Byrski, T. Huzarski, 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

R. Eils, R. Scott, U. Hamann, 2009, Breast Cancer Research and Treatment.

Hereditary ovarian cancer in Poland.

A. Jakubowska, J. Lubiński, S. Narod, 2004, International journal of cancer.

Hereditary ovarian cancer in Poland

A. Jakubowska, J. Lubiński, S. Narod, 2003 .

Transmission of mutant alleles to female offspring of BRCA1 carriers in Poland.

A. Jakubowska, J. Lubiński, T. Byrski, 2005, Journal of Medical Genetics.

LDL-R and Apo-B-100 gene mutations in Polish familial hypercholesterolemias

J. Lubiński, M. Naruszewicz, B. Górski, 1998, Human Genetics.

A common missense variant in BRCA2 predisposes to early onset breast cancer

J. Lubiński, S. Narod, B. Górski, 2005, Breast Cancer Research.

A common nonsense mutation of the BLM gene and prostate cancer risk and survival.

P. Jarzemski, A. Jakubowska, J. Lubiński, 2013, Gene.

BRCA1 testing

J. Lubiński, B. Górski, 2008, Hereditary cancer in clinical practice.

High Incidence of 4153delA BRCA1 Gene Mutations in Lithuanian Breast- and Breast-ovarian Cancer Families

J. Lubiński, J. Gronwald, B. Górski, 2005, Breast Cancer Research and Treatment.

Founder mutations in the BRCA1 gene in west Belarusian breast‐ovarian cancer families

A. Jakubowska, J. Lubiński, T. Byrski, 2001, Clinical genetics.

Detection of germline mutations in the BRCA1 gene by RNA‐based sequencing

A. Jakubowska, J. Lubiński, C. Cybulski, 2001, Human mutation.

Common variants of DNA repair genes and malignant melanoma.

J. Kładny, A. Jakubowska, C. Cybulski, 2008, European journal of cancer.

Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism

R. Scott, U. Hamann, A. Jakubowska, 2008, BMC Cancer.

Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer.

J. Kładny, T. Dębniak, B. Górski, 2000, European journal of cancer.

Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer

R. Scott, J. Lubiński, C. Cybulski, 2004, International journal of cancer.

CDKN2A common variants and their association with melanoma risk: a population-based study.

J. Kładny, R. Scott, J. Lubiński, 2005, Cancer research.

breast cancer A common variant of CDKN2A (p16) predisposes to

S. Narod, C. Szczylik, A. Mackiewicz, 2005 .

The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women.

R. Scott, U. Hamann, A. Jakubowska, 2008, Cancer letters.

Germline RECQL mutations are associated with breast cancer susceptibility

Aniruddh Kashyap, Jacek Majewski, Javad Nadaf, 2015, Nature Genetics.

Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility

W. Foulkes, A. Jakubowska, J. Lubiński, 2016, Nature Genetics.

A protein truncating BRCA1 allele with a low penetrance of breast cancer

J. Lubiński, S. Narod, J. Gronwald, 2004, Journal of Medical Genetics.

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

J. Kładny, J. Lubiński, S. Narod, 2007, European Journal of Human Genetics.

A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population

A. Jakubowska, J. Lubiński, S. Narod, 2008, Breast Cancer Research and Treatment.

Title Interplay between BRCA 1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

Loris, Fiona, Meindl, 2012 .

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

J. Lubiński, C. Cybulski, T. Byrski, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The 4154delA mutation carriers in the BRCA1 gene share a common ancestry

J. Lubiński, J. Gronwald, L. Tihomirova, 2008, Familial Cancer.

Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population

J. Kładny, R. Scott, J. Lubiński, 2014, Molecular Biology Reports.

Xeroderma pigmentosum genes and melanoma risk

R. Scott, C. Cybulski, T. Dębniak, 2013, International journal of cancer.

CDKN2A-positive breast cancers in young women from Poland

A. Jakubowska, J. Lubiński, S. Narod, 2007, Breast Cancer Research and Treatment.

XPD Common Variants and their Association with Melanoma and Breast Cancer Risk

J. Kładny, C. Cybulski, T. Byrski, 2006, Breast Cancer Research and Treatment.

CDKN 2 A Common Variants and Their Association with Melanoma Risk : A Population-Based Study

J. Kładny, R. Scott, J. Lubiński, 2005 .

CDKN2A common variant and multi‐organ cancer risk—a population‐based study

R. Scott, J. Lubiński, S. Narod, 2006, International journal of cancer.

Clinical characteristics of breast cancer in patients with an NBS1 mutation

A. Jakubowska, J. Lubiński, S. Narod, 2013, Breast Cancer Research and Treatment.

BRCA1 mutation, leptin and estrogen levels in breast cancer patients.

B. Górski, A. Chudecka-Głaz, I. Rzepka-górska, 2005, European journal of gynaecological oncology.

Mutations in the von Hippel-Lindau Tumour Suppressor Gene in Central Nervous System Hemangioblastomas

A. Jakubowska, J. Lubiński, W. Kozlowski, 2004, Hereditary cancer in clinical practice.

Comparison of Alu-PCR, microsatellite instability, and immunohistochemical analyses in finding features characteristic for hereditary nonpolyposis colorectal cancer

J. Kładny, A. Jakubowska, J. Lubiński, 2001, Journal of Cancer Research and Clinical Oncology.

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

H A Risch, J. Hopper, M. Southey, 2008, British Journal of Cancer.

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.

Victoria L. Cafourek, S. Cross, M. Beckmann, 2011, Journal of the National Cancer Institute.

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

Patrick Neven, Päivi Heikkilä, Giu-Cheng Hsu, 2011, Human molecular genetics.

Hereditary breast and ovarian cancer

J. Lubiński, T. Byrski, T. Huzarski, 2008, Hereditary Cancer in Clinical Practice.

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

A. Jakubowska, J. Lubiński, S. Narod, 2000, American journal of human genetics.

Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland

A. Jakubowska, J. Lubiński, S. Narod, 2020, Cancers.

Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients

C. Szczylik, L. Bodnar, B. Górski, 2016, Hereditary cancer in clinical practice.

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis.

A. Jakubowska, J. Lubiński, S. Narod, 2015, The Lancet. Oncology.

First recurrent large genomic rearrangement in the BRCA1 gene found in Poland.

R. Scott, J. Lubiński, C. Cybulski, 2014, Cancer epidemiology.

Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families

J. Lubiński, C. Cybulski, T. Huzarski, 2013, Molecular Biology Reports.

Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology

J. Kładny, R. Scott, A. Jakubowska, 2009, Breast Cancer Research and Treatment.

The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation Carriers

R. Scott, U. Hamann, A. Jakubowska, 2007, Cancer Epidemiology Biomarkers & Prevention.

The RAD 51 135 G > C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA 1 Mutation Carriers

R. Scott, U. Hamann, A. Jakubowska, 2007 .

Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks

R. Scott, U. Hamann, A. Jakubowska, 2007, Breast Cancer Research and Treatment.

The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs

A. Jakubowska, J. Lubiński, S. Narod, 2005 .

A high proportion of founder BRCA1 mutations in Polish breast cancer families

A. Jakubowska, J. Lubiński, S. Narod, 2004, International journal of cancer.

Ovarian cystadenoma as a characteristic feature of families with hereditary ovarian cancers unassociated with BRCA1 and BRCA2 mutations.

A. Jakubowska, J. Lubiński, T. Byrski, 2004, Journal of applied genetics.

A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer

R. Scott, A. Jakubowska, J. Lubiński, 2003, European Journal of Human Genetics.

Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.

Anna Jakubowska, Bohdan Górski, Tomasz Byrski, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Breast Cancer Risk Reduction Associated with the RAD 51 Polymorphism among Carriers of the BRCA 1 5382 insC Mutation in Poland 1

A. Jakubowska, J. Lubiński, S. Narod, 2003 .

Molecular basis of inherited predispositions for tumors.

A. Jakubowska, J. Lubiński, E. Grabowska, 2002, Acta biochimica Polonica.

Molecular Analyses in Diagnosis of High Genetic Predispositions to Malignancies

J. Kładny, A. Jakubowska, J. Lubiński, 2000 .

Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland

A. Jakubowska, J. Lubiński, S. Narod, 2015, Clinical genetics.

BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population

D. Murawa, R. Scott, J. Lubiński, 2018, PloS one.

Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland

D. Murawa, R. Scott, J. Lubiński, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

F. Couch, O. Olopade, T. Rebbeck, 2007, American journal of human genetics.

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband

J. Lubiński, S. Narod, P. Sun, 2009, British Journal of Cancer.

Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skin

J. Kładny, J. Lubiński, C. Cybulski, 2004, Melanoma research.

The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men

A. Jakubowska, J. Lubiński, S. Narod, 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles

K. Muir, A. Lophatananon, A. Borkowski, 2013, British Journal of Cancer.

An inherited NBN mutation is associated with poor prognosis prostate cancer

A Jakubowska, A. Borkowski, P. Jarzemski, 2012, British Journal of Cancer.

CHEK2 mutations and HNPCC‐related colorectal cancer

J. Kładny, A. Jakubowska, J. Lubiński, 2010, International journal of cancer.

The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population

A. Jakubowska, J. Lubiński, S. Narod, 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Estrogen receptor status in CHEK2‐positive breast cancers: implications for chemoprevention

A. Jakubowska, J. Lubiński, C. Cybulski, 2009, Clinical genetics.

Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.

A. Jakubowska, J. Lubiński, S. Narod, 2008, Carcinogenesis.

Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer

J. Lubiński, M. Słojewski, C. Cybulski, 2008, International journal of cancer.

BRCA1 mutations and prostate cancer in Poland

A. Jakubowska, J. Lubiński, S. Narod, 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Epistatic Relationship between the Cancer Susceptibility Genes CHEK2 and p27

J. Kładny, A. Jakubowska, J. Lubiński, 2007, Cancer Epidemiology Biomarkers & Prevention.

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

J. Kładny, J. Lubiński, S. Narod, 2007, European Journal of Human Genetics.

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

A. Borkowski, A. Jakubowska, J. Lubiński, 2006, Journal of Medical Genetics.

cancerwith an increased risk of prostate A large germline deletion in the Chek2 kinase gene

A. Jakubowska, J. Lubiński, R. Zdrojowy, 2006 .

A novel founder CHEK2 mutation is associated with increased prostate cancer risk.

J. Lubiński, R. Czajka, S. Narod, 2004, Cancer research.

NBS1 Is a Prostate Cancer Susceptibility Gene

A. Jakubowska, J. Lubiński, S. Narod, 2004, Cancer Research.

Advances in Brief A Novel Founder CHEK 2 Mutation is Associated with Increased Prostate Cancer Risk

J. Lubiński, R. Czajka, S. Narod, 2004 .

A Novel Founder CHEK 2 Mutation is Associated with Increased Prostate Cancer Risk

R. Czajka, S. Narod, C. Cybulski, 2004 .

The presence of prostate cancer at biopsy is predicted by a number of genetic variants

P. Jarzemski, A. Jakubowska, J. Lubiński, 2014, International journal of cancer.

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population

J. Lubiński, J. Gronwald, B. Górski, 2012, Molecular Biology Reports.

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

W. Chung, V. Pankratz, F. Couch, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.

A. Jakubowska, J. Lubiński, S. Narod, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

J. Hopper, D. Easton, P. Pharoah, 2008, British Journal of Cancer.

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.

F. Couch, B. Karlan, J. Benítez, 2011, Journal of the National Cancer Institute.

Genotyping by Induced Förster Resonance Energy Transfer (iFRET) Mechanism and Simultaneous Mutation Scanning

A. Jakubowska, J. Lubiński, C. Cybulski, 2013, Human mutation.

Genotyping by induced Förster Resonance Energy Transfer(iFRET) mechanism and simultaneous mutation scanning.

A. Jakubowska, J. Lubiński, C. Cybulski, 2013, Human mutation.

Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk

Thilo Dörk, Natalia Bogdanova, Tadeusz Dębniak, 2009, Breast Cancer Research and Treatment.

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

A. Jakubowska, J. Lubiński, S. Narod, 2007, Breast Cancer Research and Treatment.

CHEK2-Positive Breast Cancers in Young Polish Women

A. Jakubowska, J. Lubiński, S. Narod, 2006, Clinical Cancer Research.

Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population

R. Scott, A. Jakubowska, J. Lubiński, 2020, Breast Cancer.

Allelic modification of breast cancer risk in women with an NBN mutation

A. Jakubowska, J. Lubiński, S. Narod, 2019, Breast Cancer Research and Treatment.

Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish population

R. Scott, J. Lubiński, C. Cybulski, 2020, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

Marc Vidal, Dieter Niederacher, Roderic Guigó, 2011, PLoS biology.

Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study.

J. Kładny, R. Scott, J. Lubiński, 2014, Cancer genetics.

Increased Rates of Chromosome Breakage in BRCA1 Carriers Are Normalized by Oral Selenium Supplementation

J. Lubiński, S. Narod, T. Huzarski, 2005, Cancer Epidemiology Biomarkers & Prevention.

Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations

A Jakubowska, T. Dörk, A. Jakubowska, 2008, Journal of Medical Genetics.

Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence

R. Scott, J. Lubiński, K. Durda, 2017, International journal of cancer.

A range of cancers is associated with the rs6983267 marker on chromosome 8.

A. Jakubowska, J. Lubiński, S. Narod, 2008, Cancer research.

Frequency and nature of germline Rb-1 gene mutations in a series of patients with sporadic unilateral retinoblastoma.

A. Jakubowska, J. Lubiński, B. Górski, 1999, European journal of cancer.

The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania

J. Lubiński, V. Ostapenko, J. Gronwald, 2010, Clinical genetics.

DNA testing for variants conferring low or moderate increase in the risk of cancer

J. Lubiński, C. Cybulski, T. Huzarski, 2008, Hereditary cancer in clinical practice.

MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk

J. Kładny, R. Scott, J. Lubiński, 2006, International journal of cancer.

Coverage of the Genetic Background of Breast Cancer in the Polish Population

A. Jakubowska, J. Lubiński, C. Cybulski, 2006, Hereditary cancer in clinical practice.

Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene

R. Scott, J. Lubiński, C. Cybulski, 2006, Breast Cancer Research and Treatment.

Low-risk Genes and Multi-organ Cancer Risk in the Polish Population

R. Scott, A. Jakubowska, J. Lubiński, 2006, Hereditary cancer in clinical practice.

Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene

A. Jakubowska, J. Lubiński, L. Sagan, 2002, Journal of medical genetics.

Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population

J. Kładny, R. Scott, J. Lubiński, 2014, Molecular Biology Reports.

A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet

J. Lubiński, S. Narod, C. Cybulski, 2006, Hereditary cancer in clinical practice.

Selenium and the risk of cancer in BRCA1 carriers

A. Jakubowska, J. Lubiński, K. Durda, 2011, Hereditary Cancer in Clinical Practice.

Optimization of experimental conditions for RNA‐based sequencing of MLH1 and MSH2 genes

J. Kładny, R. Scott, A. Jakubowska, 2001, Human mutation.

Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients

B. Górski, A. Chudecka-Głaz, I. Rzepka-górska, 2004, Breast Cancer Research and Treatment.

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

D. Easton, J. Hopper, D. Easton, 2005, Journal of Medical Genetics.

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families

R. Scott, J. Lubiński, C. Cybulski, 2015, Hereditary cancer in clinical practice.

Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.

B. Górski, Janina Suchy, J. Gardovskis, 2007, Anticancer research.

BRCA1 mutations and colorectal cancer in Poland

Anna Jakubowska, Rafał Wiśniowski, Tadeusz Dębniak, 2010, Familial Cancer.

Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation.

J. Lubiński, S. Narod, T. Huzarski, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Cisplatin chemotherapy in the treatment of BRCA1-positive metastatic breast cancer (MBC).

J. Lubiński, S. Narod, C. Cybulski, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast cancer susceptibility genes.

J. Kładny, R. Scott, A. Jakubowska, 2007, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS

Jane E. Carpenter, Lara E Sucheston-Campbell, Ali Amin Al Olama, 2016 .

Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families

J. Lubiński, C. Cybulski, T. Huzarski, 2013, Molecular Biology Reports.

Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk.

U. Hamann, A. Jakubowska, J. Lubiński, 2007, Journal of Medical Genetics.

Non-random transmission of mutant alleles to female offspring of BRCA1 carriers in Poland

A. Jakubowska, J. Lubiński, S. Narod, 2003, Journal of medical genetics.

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Jane E. Carpenter, Lara E Sucheston-Campbell, A. Whittemore, 2016, Journal of Medical Genetics.

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

S. Narod, C. Cybulski, T. Byrski, 2011, Hereditary Cancer in Clinical Practice.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

V. Pankratz, F. Couch, T. Rebbeck, 2011, Human molecular genetics.

First recurrent large genomic rearrangement in the BRCA1 gene found in Poland.

J. Lubiński, C. Cybulski, J. Gronwald, 2014, Cancer epidemiology.

Serum YKL-40 levels in patients with ovarian cancer and women with BRCA1 gene mutation--comparison to CA 125 antigen.

I. Wojciechowska, B. Górski, A. Chudecka-Głaz, 2009, European journal of gynaecological oncology.